Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Non-Submissions To UK HTA Body Could Increase Unless Commercial Environment Improves, Warns Industry
May 01 2025
•
By
Leela Barham
Making the UK market more attractive would incentivize companies to submit evidence to Health technology appraisal body NICE.
(Shutterstock)
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from United Kingdom
More from Health Technology Assessment